Literature DB >> 10482614

Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence.

S K Kurz1, M J Reddehase.   

Abstract

The lungs are a significant organ site of murine cytomegalovirus (mCMV) latency. We have shown that activity of the major immediate-early promoter (MIEP), which drives the transcription from the ie1-ie3 transcription unit, does not inevitably initiate the productive cycle (S. K. Kurz, M. Rapp, H.-P. Steffens, N. K. A. Grzimek, S. Schmalz, and M. J. Reddehase, J. Virol. 73:482-494, 1999). Thus, even though MIEP activity governed by the MIEP-enhancer is unquestionably the first condition for recurrence, regulation of the enhancer by transcription factors is not the only mechanism controlling latency. Specifically, during latency, focal and stochastic MIEP activity in lung tissue was found to selectively generate IE1 transcripts, while transactivator-specifying IE3 transcripts were missing. This suggested a control of mCMV latency that is effectual at IE1-IE3 precursor mRNA cotranscriptional processing. Here we have used this model for studying the kinetics of reactivation and recurrence in individual lung tissue pieces after hematoablative, genotoxic treatment. Notably, reactivation was triggered, but the number of transcriptionally active foci in the lungs did not increase over time. This result is not compatible with a model of spontaneous reactivations accumulating after withdrawal of immune control. Instead, the data support the idea that reactivation is an induced event. In some pieces, focal reactivation generated IE3 transcripts but not gB transcripts, while other pieces contained foci that had proceeded to gB transcription, and only a few foci actually reached the state of virus recurrence. This finding indicates the existence of several sequentially ordered control points in the transition from mCMV latency to recurrence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482614      PMCID: PMC112881          DOI: 10.1128/JVI.73.10.8612-8622.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Activation and regulation of human cytomegalovirus early genes.

Authors:  D H Spector
Journal:  Intervirology       Date:  1996       Impact factor: 1.763

2.  Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals.

Authors:  K Kondo; J Xu; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 3.  Cytomegalovirus infection.

Authors:  P Ljungman; H Einsele
Journal:  Curr Opin Hematol       Date:  1994-11       Impact factor: 3.284

4.  Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs.

Authors:  S Kurz; H P Steffens; A Mayer; J R Harris; M J Reddehase
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 5.  Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.

Authors:  P Ljungman
Journal:  Semin Respir Infect       Date:  1995-12

Review 6.  Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts.

Authors:  S R Riddell
Journal:  Semin Respir Infect       Date:  1995-12

7.  Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors.

Authors:  C Söderberg-Nauclér; K N Fish; J A Nelson
Journal:  Cell       Date:  1997-10-03       Impact factor: 41.582

Review 8.  Prevention and treatment of cytomegalovirus pneumonia in transplant recipients.

Authors:  J A Zaia
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

9.  Mouse cytomegalovirus reactivation in severe combined immune deficient mice after implantation of latently infected salivary gland.

Authors:  K Schmader; S C Henry; R J Rahija; Y Yu; G G Daley; J D Hamilton
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.

Authors:  S Jonjić; I Pavić; B Polić; I Crnković; P Lucin; U H Koszinowski
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  60 in total

1.  Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.

Authors:  N K Grzimek; D Dreis; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth.

Authors:  A Angulo; P Ghazal; M Messerle
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs.

Authors:  R Holtappels; M F Pahl-Seibert; D Thomas; M J Reddehase
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6.

Authors:  Kazuhiro Kondo; Junji Sashihara; Kazuya Shimada; Masaya Takemoto; Kiyoko Amo; Hiromi Miyagawa; Koichi Yamanishi
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice.

Authors:  Charles H Cook; Joanne Trgovcich; Peter D Zimmerman; Yingxue Zhang; Daniel D Sedmak
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 6.  Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency.

Authors:  Mark F Stinski; Hiroki Isomura
Journal:  Med Microbiol Immunol       Date:  2007-12-19       Impact factor: 3.402

Review 7.  Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle.

Authors:  Gerd G Maul; Dmitri Negorev
Journal:  Med Microbiol Immunol       Date:  2008-02-09       Impact factor: 3.402

Review 8.  Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection.

Authors:  Jürgen Podlech; Stefan Ebert; Marc Becker; Matthias J Reddehase; Michael Stassen; Niels A W Lemmermann
Journal:  Med Microbiol Immunol       Date:  2015-02-04       Impact factor: 3.402

9.  Immune evasion proteins enhance cytomegalovirus latency in the lungs.

Authors:  Verena Böhm; Christof K Seckert; Christian O Simon; Doris Thomas; Angélique Renzaho; Dorothea Gendig; Rafaela Holtappels; Matthias J Reddehase
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

10.  Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response.

Authors:  Ramon Arens; Peng Wang; John Sidney; Andrea Loewendorf; Alessandro Sette; Stephen P Schoenberger; Bjoern Peters; Chris A Benedict
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.